Kori Wallace - Concepedia

Author

Kori Wallace

AbbVie (United States)

Also Known As

K L Wallace, K Wallace, K. Wallace, Kori L Wallace, Kori L. Wallace, Kori Wallace, Wallace, K.

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)KU Leuven AbbVie (Germany)University of Calgary Western University

About

Kori Wallace is an author at AbbVie (United States) specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	2K
2	Cell Biology	3	3	270
3	Cellular Physiology	2	2	168
4	Public Health	1	1	22
5	Cellular Therapies	1	1	61

Kori Wallace

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt, The Lancet GastroenterologyTight Control ManagementClinical GastroenterologyUlcerative ColitisMedicine	2017	883
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials Geert D’Haens, Remo Panaccione, Filip Baert, The Lancet RheumatologyInduction TherapyImmunologyGastroenterologyClinical Trials	2022	362
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial Marc Ferrante, Remo Panaccione, Filip Baert, The Lancet Fortify Maintenance TrialRheumatologyWithdrawal Phase 3GastroenterologyTreatment Option	2022	294
P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease Renata Polanowska‐Grabowska, Kori Wallace, Joshua J. Field, Arteriosclerosis Thrombosis and Vascular Biology	2010	175
Selenium and Colorectal Adenoma: Results of a Pooled Analysis Elizabeth T. Jacobs, Ruixuan Jiang, David S. Alberts, JNCI Journal of the National Cancer Institute	2004	157
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study Brian G. Feagan, Julián Panés, Marc Ferrante, The Lancet. Gastroenterology & hepatology Autoimmune DiseaseOpen-label Extension StudyImmunologyGastroenterologyClinical Gastroenterology	2018	156
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines Kori Wallace, Melissa A. Marshall, Susan I. Ramos, Blood	2009	153
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease Kori Wallace, Joel Linden Blood	2010	150
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease Laurent Peyrin‐Biroulet, J. Casey Chapman, Jean‐Frédéric Colombel, New England Journal of Medicine	2024	126
Leukocyte compartments in the mouse lung: Distinguishing between marginated, interstitial, and alveolar cells in response to injury Kathryn E. Barletta, R. Cagnina, Kori Wallace, Journal of Immunological Methods InflammationLung DepositionLung InflammationGranulocyteAlveolar Cells	2011	107

Page 1